When did XORTX THERAPEUTICS INC (XRTX) report earnings last quarter?
XORTX THERAPEUTICS INC (XRTX) last reported earnings on 3/30/2026.
NASDAQ:XRTX • CA98420Q3061
Past quarterly earnings results for XORTX THERAPEUTICS INC (XRTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | - | - | - | - | ||||
| Q3 2025 | - | - | - | - | ||||
| Q2 2025 | - | - | - | - | ||||
| Q1 2025 | - | - | - | - | ||||
| Q4 2024 | -0.30 | - | -15.38% | - | - | |||
| Q3 2024 | -0.26 | - | - | - | - | |||
| Q2 2024 | -0.28 | - | 94.81% | - | - | |||
| Q1 2024 | -1.24 | -0.26 | -372.20% | 74.95% | - | - | ||
| Q4 2023 | -0.26 | - | 97.08% | - | - | |||
| Q3 2023 | -0.26 | - | -8.41% | - | - | |||
| Q2 2023 | -5.45 | -11.36 | 52.08% | -0.83% | - | - | ||
| Q1 2023 | -4.95 | -10.45 | 52.65% | 57.69% | - | - | ||
| Q4 2022 | -9.00 | -12.27 | 26.66% | -61.06% | - | - | ||
| Q3 2022 | -0.24 | - | - | - | - | |||
| Q2 2022 | -5.40 | -10.83 | 50.14% | - | - | - | ||
| Q1 2022 | -11.70 | -8.72 | -34.19% | - | - | - | ||
| Q4 2021 | -5.59 | - | - | - | - | |||
| Q3 2021 | - | - | - | - | ||||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
XORTX THERAPEUTICS INC (XRTX) last reported earnings on 3/30/2026.
XORTX THERAPEUTICS INC (XRTX) missed EPS estimates and missed revenue estimates in the most recent quarter.